In a market moving as quickly as AI, investors say that they aren't looking for companies with technology moats, but rather ...

Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic immune-mediated diseases, today announced its launch with $120 million in funding. The ...

Bengaluru-based payment solutions provider Juspay is in discussions with Warburg Pincus, Kedaara Capital, and Norwest Venture ...

Private-equity veteran Richard Lichter launched Causeway Equity Partners, looking to capitalize on the growing numbers of ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. | The Fierce Biotech Fundraising Tracker records ...

2025 will be the year of personalized health data. For women, this shift is especially significant. Hormonal data will ...

The so-called AI boom has been going on for more than two years now, and 2024 saw a real acceleration in both the development ...

US venture capital firm Accel, which has backed a slew of unicorns in India including Flipkart and Swiggy, has mopped up $650 million (approximately Rs 5,500 crore) for its eighth India fund, show ...

Venture Intelligence reports $31.1 Billion PE-VC investments in Indian companies in 2024, slightly lower than 2023 figures.

The round included participation from Sherpa Capital, CDH Investments and an unnamed strategic investor, along with existing ...